Immune Response Research Solutions
Cytokine Markers and MoreImmune and inflammatory response are elevated in most diseases. We have strong solutions for detecting these responses. These includecytokine markers andpanels.Here's a new pub referencing use of one of ourInterleukin Markers. ArdoSabir and AndiSumidarti.Interleukin-6 expression on inflammed rat dental pulp tissue after capped withTrigona sp. propolis. Saudi Journal of Biological Sciences Volume 24, Issue 5, July 2017, Pages 1034-1037. doi.org/10.1016/j.sjbs.2016.12.019 ...Four rats were sacrificed at 6 h, 2 days, 4 days and 7 days respectively. The teeth and surrounding bone were resected, fixed in Bouin ’s fixative for 24 h, decalcified with acetic acid/formal saline for 7 days, embedded in paraffin and sectioned serially at 6 μm thickness. The sections were stained with IL-6 monoclonal antibody (Neuromics, USA) using immunohistochemistry method and viewed by light microscopy...Image: Interleukin-6 expression on rats dental pulp tissue. Normal dental pulp with no treatment (negative control) in groups I (A –B) and inflamed dental pulp in groups II (C–D), III (E–F), IV (G–H) and V (I–J), capped with Ethanolic Extract Propolis (EEP), Extract Flavonoid-Propolis (EFP), Extract Non-Flavonoid Propolis (ENFP), and Calcium Hydroxide (Ca(OH)2), respectively. Arrows show IL-6 expression. Immunohistoch emistry method, DAB chromogen, original magnification 200×.
Prevalences, nuances of presentation, and likely clinical course of myocarditis after use of some vaccines against SARS-CoV-2 are in sharper view after additions to the literature this week.Medscape Medical News
Immune checkpoint inhibitors can be effective in patients with non-small cell lung cancer and mild interstitial lung disease, but with a greater risk.Medscape Medical News
The acquisition adds non-medical, in-home care to Arkansas Hospice's services.
In the article “New treatments for chronic urticaria” by P Kolkhir et al (Ann Allergy Asthma Immunl 2020:124(1): 2-12), the following text has been removed. The article has been corrected online at https://doi.org/10.1016/j.anai.2019.08.014.
Technology is one of those items with which all clinicians (probably everyone) seem to have a love-hate relationship. The electronic medical record has made documenting and billing patient encounters much easier, yet at the same time, it seems to have erected a barrier between the patient and provider. Along with the growth of the electronic health record has been an explosion in the use of handheld devices and health-related applications (apps). These apps allow for more engagement and involvement with patients, including health monitoring by providers.
We thank the respondents to our article1 for their insightful comments. Although we have matched subjects in both cohorts by age, sex, comorbidities, and index date, Lin et al2 indicate a lack of adjustment for co-medication status, including the use of corticosteroids and disease-modifying antirheumatic drugs (DMARDs), in the propensity score. We agree that these medications are important confounders on fracture. We therefore had conducted multivariate analysis in t he published article by adjustment for corticosteroids, DMARDs, and phototherapy.
We read with great interest the article by Lin et al1 reporting the association of incidental fractures in patients with atopic dermatitis (AD). We appreciate the authors who collected data from Taiwan's National Health Insurance Research Database and conducted a great cohort study. Nevertheless, we highlight some key points.